ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 170 filers reported holding ASCENDIS PHARMA A/S in Q3 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,108,530 | +6.9% | 54,555 | +1.8% | 0.00% | 0.0% |
| Q2 2023 | $4,780,676 | -13.8% | 53,565 | +3.5% | 0.00% | 0.0% |
| Q1 2023 | $5,546,812 | +88620.6% | 51,733 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $6,252 | -99.9% | 51,192 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,285,000 | +14.4% | 51,186 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $4,619,000 | -17.7% | 49,696 | +3.9% | 0.00% | 0.0% |
| Q1 2022 | $5,615,000 | -10.9% | 47,850 | +2.1% | 0.00% | 0.0% |
| Q4 2021 | $6,305,000 | -11.7% | 46,873 | +4.6% | 0.00% | 0.0% |
| Q3 2021 | $7,140,000 | +22.6% | 44,796 | +1.2% | 0.00% | 0.0% |
| Q2 2021 | $5,824,000 | +4.0% | 44,277 | +1.9% | 0.00% | 0.0% |
| Q1 2021 | $5,601,000 | -21.6% | 43,463 | +1.4% | 0.00% | 0.0% |
| Q4 2020 | $7,148,000 | +18.2% | 42,864 | +9.4% | 0.00% | 0.0% |
| Q3 2020 | $6,048,000 | +6.9% | 39,196 | +2.4% | 0.00% | 0.0% |
| Q2 2020 | $5,660,000 | +34.3% | 38,273 | +2.2% | 0.00% | 0.0% |
| Q1 2020 | $4,215,000 | -53.6% | 37,432 | -42.7% | 0.00% | 0.0% |
| Q4 2019 | $9,082,000 | +190.1% | 65,294 | +100.8% | 0.00% | 0.0% |
| Q3 2019 | $3,131,000 | -16.8% | 32,515 | -0.5% | 0.00% | 0.0% |
| Q2 2019 | $3,764,000 | +2.9% | 32,691 | +5.2% | 0.00% | 0.0% |
| Q1 2019 | $3,657,000 | -5.1% | 31,073 | -49.5% | 0.00% | 0.0% |
| Q4 2018 | $3,852,000 | +99.3% | 61,486 | +125.4% | 0.00% | 0.0% |
| Q3 2018 | $1,933,000 | +7.5% | 27,284 | +0.9% | 0.00% | 0.0% |
| Q2 2018 | $1,798,000 | +32.4% | 27,042 | +30.2% | 0.00% | – |
| Q1 2018 | $1,358,000 | +66.4% | 20,775 | +1.9% | 0.00% | – |
| Q4 2017 | $816,000 | +12.9% | 20,390 | +2.1% | 0.00% | – |
| Q3 2017 | $723,000 | +32.4% | 19,972 | +1.5% | 0.00% | – |
| Q2 2017 | $546,000 | +31.9% | 19,686 | +32.9% | 0.00% | – |
| Q1 2017 | $414,000 | – | 14,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |